157 related articles for article (PubMed ID: 23776335)
1. Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinoma.
Ozbay PÖ; Ekinci T; Yiǧit S; Yavuzcan A; Uysal S; Soylu F; Cakalagaoglu F
Onco Targets Ther; 2013; 6():621-7. PubMed ID: 23776335
[TBL] [Abstract][Full Text] [Related]
2. Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma.
Hagiwara S; Sasaki E; Hasegawa Y; Suzuki H; Nishikawa D; Beppu S; Terada H; Sawabe M; Takahashi M; Hanai N
Cancer Med; 2021 Feb; 10(4):1335-1346. PubMed ID: 33565282
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of proliferation-associated markers Ag-NOR and Ki-67 does not contribute to the prediction of lymph node metastases in squamous cell carcinoma of the vulva.
Emanuels AG; Burger MP; Hollema H; Koudstaal J
Hum Pathol; 1996 Aug; 27(8):807-11. PubMed ID: 8760014
[TBL] [Abstract][Full Text] [Related]
4. Occult lymph node metastases in early stage vulvar carcinoma patients.
Knopp S; Holm R; Tropé C; Nesland JM
Gynecol Oncol; 2005 Nov; 99(2):383-7. PubMed ID: 16051338
[TBL] [Abstract][Full Text] [Related]
5. CD109 expression is upregulated in penile squamous cell carcinoma.
Dong F; Wang J; Xu Y; Cheng Z; Chen X; Wang Y; Liu J
Oncol Lett; 2017 Nov; 14(5):6012-6016. PubMed ID: 29113239
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of individualized treatment based on sentinel lymph node biopsy for early-stage vulvar cancer].
Tu H; Huang H; Gu H; Wan T; Feng Y; Liu J
Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):596-602. PubMed ID: 26675183
[TBL] [Abstract][Full Text] [Related]
7. CD109 is a potential target for triple-negative breast cancer.
Tao J; Li H; Li Q; Yang Y
Tumour Biol; 2014 Dec; 35(12):12083-90. PubMed ID: 25149155
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement.
Brambs CE; Horn LC; Mende M; Höckel M; Eckey C; Hiller GGR; Höhn AK
J Cancer Res Clin Oncol; 2022 May; 148(5):1183-1193. PubMed ID: 34495397
[TBL] [Abstract][Full Text] [Related]
9. CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells.
Zhou S; Hassan A; Kungyal T; Tabariès S; Luna JLRG; Siegel PM; Philip A
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954339
[TBL] [Abstract][Full Text] [Related]
10. CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer.
Adachi K; Sakurai Y; Ichinoe M; Tadehara M; Tamaki A; Kesen Y; Kato T; Mii S; Enomoto A; Takahashi M; Koizumi W; Murakumo Y
Virchows Arch; 2022 Apr; 480(4):819-829. PubMed ID: 34762199
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review.
Te Grootenhuis NC; Pouwer AW; de Bock GH; Hollema H; Bulten J; van der Zee AGJ; de Hullu JA; Oonk MHM
Gynecol Oncol; 2018 Mar; 148(3):622-631. PubMed ID: 29137809
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
[TBL] [Abstract][Full Text] [Related]
13. Stage IA vulvar squamous cell carcinoma: an analysis of tumor invasive characteristics and risk.
Yoder BJ; Rufforny I; Massoll NA; Wilkinson EJ
Am J Surg Pathol; 2008 May; 32(5):765-72. PubMed ID: 18379417
[TBL] [Abstract][Full Text] [Related]
14. The pathology of superficially invasive, thin vulvar squamous cell carcinoma.
Dvoretsky PM; Bonfiglio TA; Helmkamp BF; Ramsey G; Chuang C; Beecham JB
Int J Gynecol Pathol; 1984; 3(4):331-42. PubMed ID: 6511160
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of E-cadherin and β-catenin in the vulvar squamous cell carcinoma tissues].
Jia L; Ouyang L; Zhou Y; Song ZX; Tong X; Li B; Zhang ST; He Z
Zhonghua Fu Chan Ke Za Zhi; 2013 Jun; 48(6):437-41. PubMed ID: 24103123
[TBL] [Abstract][Full Text] [Related]
16. Staining characterization by immunohistochemistry of tumor cancer antigen in patients with endometrial cancer.
Metindir J; Dilek GB; Pak I
Eur J Gynaecol Oncol; 2008; 29(5):489-92. PubMed ID: 19051819
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma.
Tringler B; Grimm C; Sliutz G; Leodolter S; Speiser P; Reinthaller A; Hefler LA
Gynecol Oncol; 2005 Oct; 99(1):80-3. PubMed ID: 16009408
[TBL] [Abstract][Full Text] [Related]
18. The Significance of CD109 Expression in Oropharyngeal Squamous Cell Carcinoma.
Tsutsumi S; Momiyama K; Ichinoe M; Kato T; Mogi S; Miyamoto S; Murakumo Y; Yamashita T
Anticancer Res; 2022 Apr; 42(4):2061-2070. PubMed ID: 35347029
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma.
Ye BG; Sun HC; Zhu XD; Chai ZT; Zhang YY; Ao JY; Cai H; Ma DN; Wang CH; Qin CD; Gao DM; Tang ZY
Oncotarget; 2016 May; 7(20):29333-45. PubMed ID: 27121053
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer.
Kim SY; Choi KU; Hwang C; Lee HJ; Lee JH; Shin DH; Kim JY; Sol MY; Kim JH; Kim KH; Suh DS; Kwon BS
J Pathol Transl Med; 2019 Jul; 53(4):244-252. PubMed ID: 31316041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
